225 related articles for article (PubMed ID: 27506748)
1. Functional and proteomic alterations of plasma high density lipoproteins in type 1 diabetes mellitus.
Manjunatha S; Distelmaier K; Dasari S; Carter RE; Kudva YC; Nair KS
Metabolism; 2016 Sep; 65(9):1421-31. PubMed ID: 27506748
[TBL] [Abstract][Full Text] [Related]
2. Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case-control study.
Gourgari E; Ma J; Playford MP; Mehta NN; Goldman R; Remaley AT; Gordon SM
Cardiovasc Diabetol; 2019 Mar; 18(1):43. PubMed ID: 30922315
[TBL] [Abstract][Full Text] [Related]
3. Body mass index and glycemic control influence lipoproteins in children with type 1 diabetes.
Vaid S; Hanks L; Griffin R; Ashraf AP
J Clin Lipidol; 2016; 10(5):1240-7. PubMed ID: 27678442
[TBL] [Abstract][Full Text] [Related]
4. Glycemic control and high-density lipoprotein characteristics in adolescents with type 1 diabetes.
Medina-Bravo P; Medina-Urrutia A; Juárez-Rojas JG; Cardoso-Saldaña G; Jorge-Galarza E; Posadas-Sánchez R; Coyote-Estrada N; Nishimura-Meguro E; Posadas-Romero C
Pediatr Diabetes; 2013 Sep; 14(6):399-406. PubMed ID: 23057424
[TBL] [Abstract][Full Text] [Related]
5. Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.
Boemi M; Leviev I; Sirolla C; Pieri C; Marra M; James RW
Atherosclerosis; 2001 Mar; 155(1):229-35. PubMed ID: 11223446
[TBL] [Abstract][Full Text] [Related]
6. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.
Nobécourt E; Jacqueminet S; Hansel B; Chantepie S; Grimaldi A; Chapman MJ; Kontush A
Diabetologia; 2005 Mar; 48(3):529-38. PubMed ID: 15729582
[TBL] [Abstract][Full Text] [Related]
7. Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: Effects of glycemic control.
Bojanin D; Vekic J; Milenkovic T; Vukovic R; Zeljkovic A; Stefanovic A; Janac J; Ivanisevic J; Mitrovic K; Miljkovic M; Spasojevic-Kalimanovska V
Atherosclerosis; 2019 Jan; 280():14-20. PubMed ID: 30453116
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification.
Julier K; Mackness MI; Dean JD; Durrington PN
Diabet Med; 1999 May; 16(5):415-23. PubMed ID: 10342342
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment.
Feitosa AC; Feitosa-Filho GS; Freitas FR; Wajchenberg BL; Maranhão RC
Lipids Health Dis; 2013 Feb; 12():15. PubMed ID: 23398881
[TBL] [Abstract][Full Text] [Related]
10. Impact of Long-Term Poor and Good Glycemic Control on Metabolomics Alterations in Type 1 Diabetic People.
Dutta T; Kudva YC; Persson XM; Schenck LA; Ford GC; Singh RJ; Carter R; Nair KS
J Clin Endocrinol Metab; 2016 Mar; 101(3):1023-33. PubMed ID: 26796761
[TBL] [Abstract][Full Text] [Related]
11. Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c.
Gomez Rosso L; Lhomme M; Meroño T; Dellepiane A; Sorroche P; Hedjazi L; Zakiev E; Sukhorukov V; Orekhov A; Gasparri J; Chapman MJ; Brites F; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Feb; 1862(2):188-195. PubMed ID: 27815221
[TBL] [Abstract][Full Text] [Related]
12. Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes.
Murakami H; Tanabe J; Tamasawa N; Matsumura K; Yamashita M; Matsuki K; Murakami H; Matsui J; Suda T
Diabetes Res Clin Pract; 2013 Jan; 99(1):30-8. PubMed ID: 23137417
[TBL] [Abstract][Full Text] [Related]
13. Lipidomic profiling of plasma free fatty acids in type-1 diabetes highlights specific changes in lipid metabolism.
Sobczak AIS; Pitt SJ; Smith TK; Ajjan RA; Stewart AJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158823. PubMed ID: 33010452
[TBL] [Abstract][Full Text] [Related]
14. Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.
He Y; Ronsein GE; Tang C; Jarvik GP; Davidson WS; Kothari V; Song HD; Segrest JP; Bornfeldt KE; Heinecke JW
Circ Res; 2020 Oct; 127(9):1198-1210. PubMed ID: 32819213
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein composition in patients with type 1 diabetes mellitus: Impact of lipases and adipokines.
Hughes TA; Calderon RM; Diaz S; Mendez AJ; Goldberg RB
J Diabetes Complications; 2016; 30(4):657-68. PubMed ID: 26997169
[TBL] [Abstract][Full Text] [Related]
16. Effect of metformin on the high-density lipoprotein proteome in youth with type 1 diabetes.
Gourgari E; Nadeau KJ; Pyle L; Playford MP; Ma J; Mehta NN; Remaley AT; Gordon SM
Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00261. PubMed ID: 34277985
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
[TBL] [Abstract][Full Text] [Related]
18. Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles.
Amor AJ; Castelblanco E; Hernández M; Gimenez M; Granado-Casas M; Blanco J; Soldevila B; Esmatjes E; Conget I; Alonso N; Ortega E; Mauricio D
Cardiovasc Diabetol; 2020 Aug; 19(1):126. PubMed ID: 32772924
[TBL] [Abstract][Full Text] [Related]
19. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
[TBL] [Abstract][Full Text] [Related]
20. Influence of food intake, age, gender, HbA1c, and BMI levels on plasma cholesterol in 29,979 children and adolescents with type 1 diabetes--reference data from the German diabetes documentation and quality management system (DPV).
Schwab KO; Doerfer J; Naeke A; Rohrer T; Wiemann D; Marg W; Hofer SE; Holl RW;
Pediatr Diabetes; 2009 May; 10(3):184-92. PubMed ID: 19175904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
